Conversion therapy for initially unresectable hepatocellular carcinoma using a combination of toripalimab, lenvatinib plus TACE: real-world study.
Wei-Feng QuZhen-Bin DingXu-Dong QuZheng TangGui-Qi ZhuXiu-Tao FuZi-Han ZhangXin ZhangAo HuangMin TangMeng-Xin TianXi-Fei JiangRun HuangChen-Yang TaoYuan FangJun GaoXiao-Ling WuJian ZhouJia FanWei-Ren LiuYing-Hong ShiPublished in: BJS open (2022)
Better treatment responses and conversion rate for patients with uHCC were obtained with first-line t-CT. Neoadjuvant t-CT before surgery should be recommended for patients with macrovascular invasion.